61 – 70 of 118
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
A point mutation in the dynein heavy chain gene leads to striatal atrophy and compromises neurite outgrowth of striatal neurons
(
- Contribution to journal › Article
-
Mark
Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis.
(
- Contribution to journal › Article
-
Mark
Transthyretin as a potential CSF biomarker for Alzheimer's disease and dementia with Lewy bodies: effects of treatment with cholinesterase inhibitors.
(
- Contribution to journal › Article
-
Mark
Hypothalamic and Neuroendocrine Changes in Huntington's Disease.
(
- Contribution to journal › Article
-
Mark
Changes in key hypothalamic neuropeptide populations in Huntington disease revealed by neuropathological analyses.
(
- Contribution to journal › Article
- 2009
-
Mark
Increased numbers of motor activity peaks during light cycle are associated with reductions in adrenergic alpha(2)-receptor levels in a transgenic Huntington's disease rat model
(
- Contribution to journal › Article
-
Mark
Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin.
(
- Contribution to journal › Article
-
Mark
Increased levels of cocaine and amphetamine regulated transcript in two animal models of depression and anxiety.
(
- Contribution to journal › Article
-
Mark
Reduced CSF CART in dementia with Lewy bodies.
(
- Contribution to journal › Article
-
Mark
Increased orexin levels in the cerebrospinal fluid the first year after a suicide attempt.
(
- Contribution to journal › Article